Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000146981 | SCV000309728 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Invitae | RCV000456906 | SCV000554674 | benign | Familial aplasia of the vermis; Orofaciodigital syndrome I | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000146981 | SCV000729097 | benign | not specified | 2018-01-18 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV002312655 | SCV000847327 | benign | Primary ciliary dyskinesia; Inborn genetic diseases | 2014-12-15 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Athena Diagnostics Inc | RCV000146981 | SCV001879890 | benign | not specified | 2021-03-19 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000146981 | SCV000194317 | likely benign | not specified | no assertion criteria provided | clinical testing |